The framing of sickness absence as an HR inconvenience is over. At £22bn in lost output annually, it now sits on par with major operational risk categories. The organisations closing the gap are the ones that treat absence data the way they treat financial data: tracked in real time, reported against targets, actioned early.
The number is no longer ignorable
The UK lost 158 million working days to sickness absence in 2024. That is not an HR statistic. It is a £22 billion line on the national P&L, confirmed by the Confederation of British Industry and cross-referenced in ONS Labour Force Survey data. Add the £24 billion lost to presenteeism, documented by Deloitte, and the combined workforce health cost to UK employers exceeds £46 billion annually.
Most boards have heard some version of that number. Very few have a system in place to act on it at company level. The gap between knowing and acting is where billions are lost every year, and it is a gap driven almost entirely by infrastructure: by the absence of the right data, in the right format, at the right time.
Absence data is financial data. The organisations treating it that way are pulling ahead.
Why the current approach is not working
The average UK employee loses 4.4 days to sickness absence per year, according to the CIPD’s 2024 Health and Wellbeing Survey. That same survey found that 37% of UK businesses reported an increase in stress-related absence year on year. Neither figure is surprising to anyone working in occupational health or HR. What is surprising is how few organisations have built the operational infrastructure to respond to either.
The reason is structural. In most mid-to-large employers, absence data is fragmented across at least three or four systems: line manager self-certification in an HR platform, clinical notes in an OH system (if one exists), referral tracking in an email inbox, and reporting assembled manually in a spreadsheet for monthly reviews. By the time an absence trend reaches a board paper, it is three months old and stripped of the clinical context that would make it actionable.
The board is not ignoring workforce health because it does not care. It is ignoring it because the data arriving on the table does not look like a decision.
What the data actually shows
When you disaggregate the £22bn figure, the breakdown is instructive. Mental health conditions accounted for 13.7% of all working days lost in the UK in 2023-24, according to the Health and Safety Executive. Musculoskeletal conditions accounted for a further 28% of all work-related ill health cases. Together, those two categories represent the majority of preventable, interventionable absence.
Preventable and interventionable are important words here. NICE clinical guidance is clear that physiotherapy within 14 days of a musculoskeletal absence episode reduces total sick days by approximately 40% compared to waiting for a standard GP-led pathway. Deloitte’s mental health ROI model, now the most-cited in the field, puts the return on investment for structured mental health support at £4.70 for every £1 spent.
These are not marginal gains. They are significant commercial returns on a defined category of spend. And they depend entirely on one thing: acting early. The organisations seeing those returns have built systems that trigger the right intervention at the right time, automatically, without relying on a line manager to remember or a clinician to be available.
The board question that matters
There is a question worth testing in your next senior leadership or board conversation: if someone asked you today for the return on your occupational health spend in the last 12 months, could you produce it?
Not an activity report. Not a case count. A return figure. Reduction in days lost against a baseline. Time-to-referral against a defined threshold. Cost of intervention versus cost of extended absence.
In the majority of UK organisations, the honest answer is no. Not because the people are not doing good work, but because the infrastructure does not connect the clinical events to the business outcomes in a way that can be reported upward.
The OH teams getting budget and board backing in 2026 are the ones who can walk into a meeting with a number, a trend, and a plan.
What a different approach looks like
The organisations that have closed this gap share a common operational characteristic: they have moved absence management from a reactive process to a configured one. Referrals are not made when a manager remembers to make them. They are triggered automatically when an employee reaches a defined absence threshold, whether that is three episodes in 12 months or seven consecutive days, depending on the employer’s agreed protocol.
Health surveillance is not scheduled when someone books it. It is generated automatically based on the employee’s role, risk profile, and the last date of clinical contact. New starter health questionnaires are completed digitally before day one, not chased by post three weeks after joining.
The result is not just better clinical outcomes. It is a fundamentally different relationship between the OH function and the organisations it serves. When absence data is live, referral workflows are automatic, and reporting is generated without manual assembly, the conversation with finance and HR leadership changes from reactive to strategic.
The infrastructure argument
None of this requires a headcount increase. It requires the right platform. The difference between an OH team running on a properly integrated system and one running on spreadsheets and email is not a clinical difference. It is an operational one. And in 2026, in a market where the cost of sickness absence is £22 billion and rising, it is a commercial one.
The organisations investing in that infrastructure are not doing so out of altruism. They are doing it because the alternative is measurable, quantifiable, and showing up on their P&L. The board is starting to notice.
The question is not whether to treat absence as a business problem. It already is one. The question is whether your organisation has the systems to do anything about it.
Key UK Data Points:
- £22bn total annual cost of sickness absence to UK employers (CBI, 2024)
- 158 million working days lost in the UK in 2024 (ONS Labour Force Survey)
- 4.4 days average sickness absence per employee per year (CIPD, 2024)
- 13.7% of all working days lost attributed to mental health conditions (HSE, 2023-24)
- £4.70 return per £1 invested in structured mental health support (Deloitte, 2022)
- £24bn annual productivity cost of presenteeism to UK employers (Deloitte, 2022)
